rs199472910
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PP3_StrongPP5
The ENST00000262186.10(KCNH2):c.1474C>T(p.His492Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,461,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H492L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000262186.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1474C>T | p.His492Tyr | missense_variant | 6/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.1474C>T | p.His492Tyr | missense_variant | 6/15 | 1 | NM_000238.4 | ENSP00000262186 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251464Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135918
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461820Hom.: 0 Cov.: 40 AF XY: 0.0000110 AC XY: 8AN XY: 727208
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Congenital long QT syndrome Pathogenic:1Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:12808265;PMID:19843919). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 18, 2020 | The p.His492Tyr variant in KCNH2 has been reported in the heterozygous state in at least 7 individuals with long QT syndrome (LQTS): 4 with congenital LQTS and 3 with drug induced LQTS (Inoue 2003, Itoh 2009, Hayashi 2016, Fujii 2017). The variant has also been reported in 7 individuals with a more severe phenotype who had a second variant in KCNH2 or another LQTS gene (Bando 2014, Fujii 2017). The p.His492Tyr variant segregated with disease in at least 5 affected relatives from 3 families; however the variant was also observed in unaffected family members (Itoh 2009, Bando 2014, Fujii 2017). In vitro functional studies suggest that the p.His492Tyr variant does not significantly impact protein function (Itoh 2009). This variant has been identified in 3/18394 East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org) and has been reported in ClinVar (Variation ID: 67204). Computational prediction tools and conservation analysis suggest that the p.His492Tyr variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant LQTS, though it may show reduced penetrance and a milder clinical presentation when observed in isolation and a more severe phenotype when observed in combination with other LQTS variants. ACMG/AMP Criteria applied: PS4_Moderate, PM3, PP1, PP3 - |
Short QT syndrome type 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.95; 3Cnet: 0.88). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000067204). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
Long QT syndrome 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 05, 2019 | The KCNH2 c.1474C>T (p.His492Tyr) missense variant has been reported in at least four studies in which it has been identified in a total of 18 individuals of Japanese descent with long QT syndrome, including six individuals (four unrelated) in a compound heterozygous state, seven individuals (five unrelated) in a heterozygous state, and five individuals (three unrelated) in a double heterozygous state with a second variant in a different gene (Itoh et al. 2009; Bando et al. 2014; Fujii et al. 2016; Izumi et al. 2016). The majority of the individuals with two variants were found to have a prolonged QTc interval and a more severe phenotype compared to individuals with the p.His492Tyr variant alone (Fujii et al. 2016; Izumi et al. 2016). Fujii et al. (2016) suggest that the p.His492Tyr variant in a heterozygous state may be associated with a milder form of long QT syndrome. They also suggest that these individuals have latent long QT syndrome and presence of additional factors, such as hypokalemia, drugs, or bradycardia, may result in symptoms, as was noted in four individuals who developed syncope or torsade de pointes when other factors were also present. The variant was also found in two unaffected heterozygous family members (Bando et al. 2014), but was absent from at least 1300 controls. The His492Tyr variant is reported at a frequency of 0.00012 in the East Asian population of the Genome Aggregation Database, but this is based on two alleles so the variant is presumed to be rare. Itoh et al. (2009) performed functional studies using Chinese hamster ovary cells and found that compared to wild type, presence of the p.His492Tyr variant resulted in a mild decrease in current density, and did not have a dominant negative effect. Based on the collective evidence, the p.His492Tyr variant is classified as likely pathogenic for long QT syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 15, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.His492 amino acid residue in KCNH2. Other variant(s) that disrupt this residue have been observed in individuals with KCNH2-related conditions (PMID: 30369311), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this missense change does not substantially affect KCNH2 function (PMID: 19843919). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 67204). This missense change has been observed in individuals with clinical features of long QT syndrome (PMID: 12808265, 19843919, 24057343, 27816319). This variant is present in population databases (rs199472910, gnomAD 0.01%). This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 492 of the KCNH2 protein (p.His492Tyr). - |
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 11, 2021 | - - |
KCNH2-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 24, 2023 | The KCNH2 c.1474C>T variant is predicted to result in the amino acid substitution p.His492Tyr. This variant was reported in multiple individuals with long-QT syndrome (Case 4, Itoh. 2009. PubMed ID: 19843919; reported as HERG H492Y, Inoue. 2003. PubMed ID: 12808265; Bando et al 2013. PubMed ID: 24057343; see Table 2, Fujii. 2017. PubMed ID: 27816319). This variant was interpreted as a causative variant for long-QT syndrome (Table S7, Ware et al 2012. PubMed ID: 22581653). Functional studies suggest that variant may slightly alter KCNH2 normal function (Figure 5, Itoh. 2009. PubMed ID: 19843919). In ClinVar, this variant is interpreted as likely pathogenic/pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/67204/?new_evidence=true). This variant is reported in 0.016% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-150649596-G-A). This variant is interpreted as likely pathogenic. - |
Cardiac arrhythmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 18, 2020 | This missense variant replaces histidine with tyrosine at codon 492 of the KCNH2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study has shown that this variant causes a mild decrease in current density and did not have a dominant negative effect (PMID: 19843919). This variant has been reported in over ten Japanese individuals affected with or suspected of having long QT syndrome (PMID: 12808265, 24057343, 27041096, 27816319, 29766885). Some of these individuals who also carried a pathogenic variant in the same or different gene showed a more severe phenotype (PMID: 24057343, 27816319). Multiple heterozygous individuals did not show a prolonged QT interval (PMID: 24057343, 27816319). This variant has been identified in 3/251464 chromosomes (3/18394 East Asian chromosomes) in the general population by the Genome Aggregation Database (gnomAD). In summary, although additional studies are required to fully establish its clinical significance, the available evidence indicates that this variant is likely pathogenic for autosomal dominant long QT syndrome, although it may show reduced penetrance and a milder clinical presentation when observed in isolation and a more severe phenotype when observed in combination with other pathogenic variants. Therefore, this variant is classified as Likely Pathogenic. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | The p.H492Y variant (also known as c.1474C>T), located in coding exon 6 of the KCNH2 gene, results from a C to T substitution at nucleotide position 1474. The histidine at codon 492 is replaced by tyrosine, an amino acid with similar properties. This variant has been detected in a number of individuals of Japanese ancestry with long QT syndrome (LQTS), suspected LQTS, or acquired LQTS precipitated by an additional factor. However, individuals with this and a second variant in LQTS-associated genes had more severe phenotype, and some individuals with only the p.H492Y were apparently unaffected (Inoue M et al. Circ J, 2003 Jun;67:495-8; Nagaoka I et al. Circ J, 2008 May;72:694-9; Itoh H et al. Circ Arrhythm Electrophysiol, 2009 Oct;2:511-23; Yoshinaga M et al. Circ Arrhythm Electrophysiol, 2014 Feb;7:107-12; Bando S et al. Heart Vessels, 2014 Jul;29:554-9; Izumi G et al. Pediatr Cardiol, 2016 Jun;37:962-70; Jang SY et al. Pacing Clin Electrophysiol, 2017 Mar;40:232-241; Fujii Y et al. J Cardiol, 2017 Jul;70:74-79). In vitro functional studies have indicated that this variant resulted in protein expression and peak cannel current comparable to wild type (Itoh H et al. Circ Arrhythm Electrophysiol, 2009 Oct;2:511-23; Perry MD et al. J Physiol, 2016 Jul;594:4031-49). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at